$3.16 +0.06 (1.94%) Cardiome Pharma Corp - NASDAQ

Sep. 28, 2016 | 03:59 PM
Last Trade: 3.16
Trade Time: Sep 28 03:59 PM Eastern Daylight Time
Change: +0.06 (1.94%)
Prev Close: 3.10
Open: 3.10
Bid: 3.15
Ask: 3.16
  1. No results found.
  1. Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency

    Benzinga | Jan. 6, 2016 | 08:04AM EST
  2. Cardiome Closes US$23 Million Bought Deal Financing

    GuruFocus | Aug. 14, 2015 | 00:03AM EST
  3. Cardiome Reports ~$15M Bought-Deal Financing

    Benzinga | Jul. 28, 2015 | 16:38PM EST
  4. Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

    Benzinga | Jul. 22, 2015 | 08:05AM EST
  5. SteadyMed and Cardiome Enter into a License Agreement for the Commercialization Rights to Trevyent Outside the U.S.

    Benzinga | Jun. 29, 2015 | 12:00PM EST
  6. Cardiome Pharma Corp. Announces Voting Results

    Benzinga | Jun. 24, 2015 | 08:31AM EST
  7. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | Jun. 5, 2015 | 04:32AM EST
  8. Cardiome and AOP Orphan Pharma Enter ESMOCARD Commercialization Agreement

    Benzinga | May. 12, 2015 | 08:32AM EST
  9. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  10. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  11. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 18:25PM EST
  12. Earnings Scheduled For March 27, 2014

    Benzinga | Mar. 27, 2014 | 05:03AM EST
  13. Benzinga's M&A Chatter for Monday November 18, 2013

    Benzinga | Nov. 18, 2013 | 17:41PM EST
  14. Cardiome Will Buy Correvio LLC, Expecting Deal to Be Immediately Accretive

    Benzinga | Nov. 18, 2013 | 14:20PM EST
  15. Cardiome Reports Commercialization Deal for Brianavess with LifePharma in Cyprus, No Terms Disclosed

    Benzinga | Sep. 24, 2013 | 11:01AM EST
Trading Center